QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 16 August 2006
doi: 10.1242/dev.02539

This Article Summary Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Z. Articles by Baldini, A. Search for Related Content PubMed PubMed Citation Articles by Zhang, Z. Articles by Baldini, A.

Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development

Zhen Zhang^1,2,*, Tuong Huynh^2,* and Antonio Baldini^1,2,3,*,

¹ Program in Cardiovascular Sciences, Baylor College of Medicine, Houston, TX 77030, USA.
² Department of Pediatrics (Cardiology), Baylor College of Medicine, Houston, TX 77030, USA.
³ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

View larger version (134K): [in a new window]   Fig. 1. Mesodermal-specific deletion of Tbx1 by Mesp1Cre. (A-D) Sagittal sections of E9.5 embryos. (A) Distribution of Tbx1-traced cells visualized by crossing Tbx1mcm/+ mice with the reporter R26R, compared with the distribution of Mesp1Cre-traced cells (B). Recombination is absent in the endoderm in the latter experiment. (C,D) Immunofluorescent staining with an anti-Tbx1 antibody on control (C) and conditional mutant (D) E9.5 embryos. Tbx1 immunoreactivity is preserved in the endoderm (arrowheads) and, to a lesser extent, in the core of the 1st pharyngeal arch (arrow in D), but not in other mesodermal domains (arrows). (E,F) Coronal sections of E9 embryos. Immunofluorescent staining with an anti-Tbx1 antibody on control (E) and M-ko embryos (F). Mesodermal expression (arrows) is eliminated in M-ko embryos, but endodermal (white arrowhead) and ectodermal (yellow arrowhead) expression are maintained. I, II and III, 1st, 2nd and 3rd pharyngeal arches; 1P, 2P and 3P, 1st, 2nd and 3rd pharyngeal pouches. Scale bar: 100 µm in A-D; 50 µm in E,F.

View larger version (97K): [in a new window]   Fig. 2. Mesodermal ablation of Tbx1 causes severe pharyngeal and cardiovascular abnormalities. (A-K) Mesp1Cre/+;Tbx1+/flox control embryos compared with (A'-K') Mesp1Cre/+;TbxE5/flox M-ko mutant embryos. Hypoplastic external ears (arrow A,A'), absence of thymus (T and asterisk, B,B'), persistent truncus arteriosus (PTA, C,C') originating from the right ventricle (D,D') and ventricular septal defect (VSD, D,D') in M-ko embryos at E18.5. (E,E') Hypoplasia of the 2nd pharyngeal arch (arrowhead) in an E10.5 M-ko embryo. (F,F') Cardiac ink injection in E10.5 embryos visualized the 3rd, 4th and 6th pharyngeal arch arteries in cotrols (F); M-ko embryos have only one pair of arteries connecting the aortic sac with the dorsal aorta (F'). (G,G') Coronal sections of E10.5 embryos revealed severe hypoplasia of the pharynx (Ph) in M-ko mutants. (H,H') Wholemount RNA in situ hybridization on E10 embryos using a Crabp1 probe as a neural crest marker. Conditional deletion mutants showed abnormal Crabp1 expressing pattern. (I,I') Whole-mount immunohistochemistry on E10 embryos with an anti-neurofilament M antibody revealed abnormalities of cranial nerve pathways in the mutant. (J,J') Whole-mount RNA in situ hybridization on E10 embryos with a Pax1 probe revealed a small 1st pouch and loss of labeling of pouches 2 and 3 in M-ko mutants. (K,K') Whole-mount immunohistochemistry on E10 embryos with an anti-Hoxb1 antibody revealed a normally specified, albeit slightly smaller, 4th pouch in M-ko mutants. The insets show coronal sections of the same embryos; the 4th pouches of M-ko embryos are not fully developed and not as close to the surface ectoderm as those of control embryos. T, thymus; H, heart; Ph, pharynx; Ao, aorta; P, pulmonary trunk; Pa, pulmonary artery; VSD, ventricular septum defect; RV/LV, right/left ventricle; RSA/LSA, right/left subclavian artery; RCA/LCA, right/left carotid artery; I, II and III, 1st, 2nd and 3rd pharyngeal arch; 3, 4 and 6, 3rd, 4th and 6th pharyngeal arch artery; 1p, 2p, 3p and 4p, 1st, 2nd, 3rd and 4th pharyngeal pouches; V, trigeminal nerve; VII/VIII, facial/acoustic nerve; IX, glossopharyngeal nerve; X, vagus nerve; XI, accessory nerve. Scale bars: 2 mm in A'; 1 mm in B',C',E',F',I',K'; 100 µm in D' and G'.

View larger version (89K): [in a new window]   Fig. 3. Phenotypic analysis of compound mutants Tbx1neo2/- and conditional rescue mutants Mesp1Cre/+;Tbx1E5/neo2. (A) Scheme of gene targeting strategy. H, HindIII. (B-M) Compound mutants Tbx1neo2/-. (B'-M') Conditional rescue mutants Mesp1Cre/+;Tbx1E5/neo2. (B,B') Immunohistochemistry using an anti-Tbx1 antibody on sagittal sections of E9.5 embryos showed very low or undetectable signal in compound mutants (B) and reactivated expression in the mesoderm (arrows) of the rescued embryo (B'). (C,C') External ears (arrowhead) are hypoplastic in compound mutants but are of normal size in rescued mutants (arrow) at E18.5. (D,D') Absence of thymus indicated by asterisk in both compound and rescued mutants at E18.5. (E,E',F,F') The cardiac outflow tract phenotype was normal in rescued embryos at E18.5. (G,G') The hypoplasia of the 2nd pharyngeal arch of compound mutants (arrowhead) was corrected in rescued embryos. (H,H') Ink injection into the heart of E10.5 embryos revealed normalization of the 6th pharyngeal arch arteries but not of the 4th pharyngeal arch arteries in rescued mutants. This is also evident from histological sections (I,I'). (J,J') Whole-mount RNA in situ hybridization on E10 embryos with a PaxI probe revealed normalization of the 2nd pharyngeal pouch but only partial development of the 3rd pharyngeal pouch (arrowhead in J') in rescued embryos. (K,K') Whole-mount immunohistochemistry on E10 embryos with an anti-Hoxb1 antibody showed a more robust labeling of the 4th pouch (arrowhead) in rescued embryos. (L,L') Whole-mount RNA in situ hybridization on E10 embryos with a Crabp1 probe revealed only a marginal improvement of neural crest cell distribution in rescued embryos (compare with the normal pattern in Fig. 2H). Similarly, immunohistochemistry on E10 embryos using an anti neurofilament M antibody showed only modest improvement in rescued embryos, especially in the caudal region of the pharynx (M,M'), compare with normal pattern in Fig. 2I). Ph, pharynx; Ao, aorta; P, pulmonary trunk; Pa, pulmonary artery; VSD, ventricular septum defect; RV/LV, right/left ventricle; RSA/LSA, right/left subclavian artery; RCA/LCA, right/left carotid artery; I and II, 1st and 2nd pharyngeal arch; 3 and 6: 3rd and 6th pharyngeal arch artery; 1p, 2p, 3p and 4p, 1st, 2nd, 3rd and 4th pharyngeal pouches; V, trigeminal nerve; VII/VIII, facial/acoustic nerve; IX, glossopharyngeal nerve; X, vagus nerve; XI, accessory nerve. Scale bars: 2mm in C'; 1 mm in D',E',G',H',K',M'; 100 µm in B',F',I'.

View larger version (69K): [in a new window]   Fig. 4. Tbx1 regulates cell proliferation in mesenchyme cells. (A,A') Tbx1 expression domain revealed by a Tbx1-lacZ knock-in allele (Tbx1+/-) at E8.5. (A') Transverse section of A. The area where cell proliferation was scored is indicated by the white box in A. (B) Transverse sections of E8.5 Mesp1Cre/+; Tbx1+/flox embryos as controls. (B') Transverse sections of E8.5 Mesp1Cre/+; Tbx1E5/flox embryos. (B,B') Immunohistochemistry staining with an anti-phospho-Histone H3 antibody to evaluate cell proliferation. (C) Mitotic index (M.I.) in pharyngeal mesenchyme at E8.5 embryos. Cells in neural tube were counted as an internal control. P values were calculated using Student's t-test. da, dorsal aorta; se, surface ectoderm; pe, pharyngeal ectoderm; pm, pharyngeal mesenchyme; P, pharynx. Scale bars: 1 mm in A; 100 µm in A'-B'.

View larger version (100K): [in a new window]   Fig. 5. Mesodermal Tbx1 affects mesodermal but not epithelial Fgf8 expression. (A-D) Whole-mount RNA in situ hybridization with an Fgf8 probe. (A',B') Transverse sections of the E8.5 embryos shown in A and B, respectively. (C',D') Coronal sections of the E9 embryos shown in C and D, respectively. Orange arrows indicate Fgf8 expression in the ectoderm. Pink arrows indicate Fgf8 expression in endoderm. Black arrowheads indicate Fgf8 expression in splanchnic mesoderm/anterior heart field. Scale bar: 100 µm in B,D,D'; 50 µm in B'.